Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-agent chemotherapy

Gynecologic Oncology

Volumn 96, Issue 3, 2005, Pages 616-620

  Matsui, Hideo ^a   Suzuka, Kiyomi ^a   Yamazawa, Koji ^a   Tanaka, Naotake ^a   Mitsuhashi, Akira ^a   Seki, Katsuyoshi ^a   Sekiya, Souei ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Chemotherapy; Drug resistance; Persistent gestational trophoblastic tumor

Indexed keywords

CHORIONIC GONADOTROPIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; FOLINIC ACID; METHOTREXATE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER REGRESSION; CANCER RELAPSE; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; MATERNAL AGE; METASTASIS; PRIORITY JOURNAL; RECURRENCE RISK; SCORING SYSTEM; SURVIVAL RATE; TITRIMETRY; TOXICITY; TREATMENT PLANNING; TROPHOBLASTIC TUMOR;

EID: 13844280396     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.11.011     Document Type: Article

References (20)

1. I.A. McNeish, S. Strickland, L. Holden, G.J.S. Rustin, M. Foskett, and M.J. Seckl Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000 J. Clin. Oncol. 20 2002 1838 1844
2. J.P. Roberts, and J.R. Lurain Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy Am. J. Obstet. Gynecol. 174 1996 1917 1924
3. H. Matsui, Y. Iitsuka, K. Seki, and S. Sekiya Comparison of chemotherapies with methotrexate (MTX), VP-16 and actinomycin-D (Act-D) in low-risk gestational trophoblastic disease-Remission rates and drug toxicities Gynecol. Obstet. Invest. 46 1998 5 8
4. K.D. Bagshawe, J. Dent, E.S. Newlands, R.H.J. Begent, and G.J.S. Rustin The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT) Br. J. Obstet. Gynaecol. 96 1989 795 802
5. L.C. Wong, Y.C. Choo, and H.K. Ma Primary oral etoposide therapy in gestational trophoblastic disease. An update Cancer 58 1986 14 17
6. R.S. Berkowitz, D.P. Goldstein, and M.R. Bernstein Ten year's experience with methotrexate and folic acid as primary therapy for gestational trophoblastic disease Gynecol. Oncol. 23 1986 111 118
7. G.J.S. Rustin, E.S. Newlands, J.M. Lutz, L. Holden, K.D. Bagshawe, and J.G. Hiscox Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increase the incidence of second tumors J. Clin. Oncol. 14 1996 2769 2773
8. C.B. Hammond, L.G. Borchert, L. Tyrey, W.T. Creasman, and R.T. Parker Treatment of metastatic trophoblastic disease: good and poor prognosis Am. J. Obstet. Gynecol. 115 1973 451 457
9. E.I. Kohorn, D.P. Goldstein, B.W. Hancock, S.J. Kim, J.R. Lurain, and E.S. Newlands Combining the staging system of the International Federation of Gynecology and Obstetrics with the scoring system of the World Health Organization for trophoblastic neoplasia. Report of Working Committee of the International Society for the Study of Trophoblastic Disease and International Gynecologic Cancer Society Int. J. Gynecol. Cancer 10 2000 84 88
10. K. Suzuka, H. Matsui, Y. Iitsuka, K. Yamazawa, K. Seki, and S. Sekiya Adjuvant hysterectomy in low-risk gestational trophoblastic disease Obstet. Gynecol. 97 2001 431 434
11. E.B. Smith, J.C. Weed, L. Tyrey, and C.B. Hammond Treatment of nonmetastatic gestational trophoblastic disease: results of methotrexate alone versus methotrexate-folinic acid Am. J. Obstet. Gynecol. 144 1982 88 92
12. L.C. Wong, Y.C. Choo, and H.K. Ma Methotrexate with citrovorum rescue in gestational trophoblastic disease Am. J. Obstet. Gynecol. 152 1985 59 62
13. J.T. Soper, D.L. Clarke-Pearson, A. Berchuck, G. Rodriguez, and C.B. Hammond 5-day methotrexate for women with metastatic gestational trophoblastic disease Gynecol. Oncol. 54 1994 76 79
14. H.D. Homesley, J.A. Blessing, J. Schlaerth, M. Rettenmaier, and F.J. Major Rapid escalation of weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease: a gynecologic oncology group study Gynecol. Oncol. 39 1990 305 308
15. D.P. Goldstein, P. Wining, and R.L. Shirley Actinomycin D as an initial therapy of gestational trophoblastic disease: a reevaluation Obstet. Gynecol. 39 1972 341 345
16. R. Osathanondh, D.P. Goldstein, and G.B. Pastorfide Actinomycin D as the primary agent for gestational trophoblastic disease Cancer 36 1975 863 866
17. E.S. Petrilli, and C.P. Morrow Actinomycin D toxicity in the treatment of trophoblastic disease. a comparison of the five-day course to single-dose administration Gynecol. Oncol. 9 1980 18 22
18. J.B. Schlaerth, C.P. Morrow, R.H. Nalick, and O. Gaddis Jr. Single-dose actinomycin D in the treatment of postmolar trophoblastic disease Gynecol. Oncol. 19 1984 53 56
19. H. Matsui, Y. Iitsuka, K. Yamazawa, N. Tanaka, A. Mitsuhashi, and K. Seki Criteria for initiating chemotherapy in patients after evacuation of mole Tumor Biol. 24 2003 140 146
20. E.I. Kohorn Is lack of response to single-agent chemotherapy in gestational trophoblastic disease associated with dose scheduling or chemotherapy resistance Gynecol. Oncol. 85 2002 36 39